CSI Market
Sign In | Register

Evofem Biosciences Inc (EVFM) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access EVFM Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Evofem Biosciences Inc adapts its asset base and funding mix.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent0.29
Restricted Cash and Cash Equivalents, Current0.29
Other Short-term Investments0.14
Cash & Short-term Investments0.00
Accounts receivable2.50
Inventories2.16
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.00
Total Current Assets6.08
Equipment/Property/Plant Net0.54
Intangible Assets0.87
Other Assets, Noncurrent0.75
Restricted Cash Current-
Operating Lease Right Of Use Asset0.15
Total Assets7.52
Liabilities
Accounts Payable, Current AC12.15
Accrued Liabilities, Current2.50
Derivative Liability, Current DE6.91
Short-term Debt DE10.36
Other Liabilities, Current66.31
Deferred Liability and Revenue0.38
Total Current Liabilities88.62
Total Long-term Debt0.00
Other liabilities, Noncurrent1.40
OperatingLeaseLiabilityNoncurrent0.03
Operating Lease Liability Current0.12
Contingent Liabilities Current0.22
Total Liabilities90.01
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock831.88
Retained Earnings / Accumulated Deficit-914.02
Accumulated Other Comprehensive Income-5.39
Other Equity-5.39
Common Stockholder's Equity-92.54
Non-controlling interests & other5.03
Total Stockholder's Equity-87.52
Liabilities & Stockholder's Equity7.52
4 historic quarters locked

Sign in to unlock the full Evofem Biosciences Inc balance sheet history.

Sign In Create Free Account

About Evofem Biosciences Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 14, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-038328

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.